Rampart Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Rampart Investment Management's BMY Position: Q4 2020 in Review
Rampart Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 14,188 shares — an estimated $855K sold.
Rampart Investment Management first reported a position in BMY in Q1 2017 and held it in 15 quarters. The position peaked at $2.77M in Q1 2018. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.
- Rampart Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
- Rampart Investment Management sold 14,188 Bristol-Myers Squibb shares in Q4 2020, an estimated $855K.
- Rampart Investment Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 15 quarters.
- Rampart Investment Management's Bristol-Myers Squibb position peaked at $2.77M in Q1 2018.
- 2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.
Based on Rampart Investment Management's 13F filing for Q4 2020.